These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15090615)

  • 21. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells.
    Lehmann K; Janda E; Pierreux CE; Rytömaa M; Schulze A; McMahon M; Hill CS; Beug H; Downward J
    Genes Dev; 2000 Oct; 14(20):2610-22. PubMed ID: 11040215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
    Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
    Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes.
    Ginès P; Li X; Brown SE; Nakamura T; Guzelian PS; Heasley LE; Schrier RW; Nemenoff RA
    Hepatology; 1996 May; 23(5):1167-73. PubMed ID: 8621150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
    Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
    Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
    Anderson LR; Sutherland RL; Butt AJ
    Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of Raf-1 protooncogene by geldanamycin causes apoptosis in human luteinized granulosa cells.
    Khan SM; Oliver RH; Dauffenbach LM; Yeh J
    Fertil Steril; 2000 Aug; 74(2):359-65. PubMed ID: 10927059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical contribution of linker proteins to Raf kinase activation.
    Anselmo AN; Bumeister R; Thomas JM; White MA
    J Biol Chem; 2002 Feb; 277(8):5940-3. PubMed ID: 11741918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of the Drosophila raf proto-oncogene by Drosophila STAT during development and in immune response.
    Kwon EJ; Park HS; Kim YS; Oh EJ; Nishida Y; Matsukage A; Yoo MA; Yamaguchi M
    J Biol Chem; 2000 Jun; 275(26):19824-30. PubMed ID: 10764759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules.
    Xu XS; Vanderziel C; Bennett CF; Monia BP
    J Biol Chem; 1998 Dec; 273(50):33230-8. PubMed ID: 9837893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of lung dysplasia induced by c-Raf-1.
    Rohrbeck A; Müller VS; Borlak J
    PLoS One; 2009 May; 4(5):e5637. PubMed ID: 19529782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: The metastasis suppressor NRDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
    Menezes SV; Kovacevic Z; Richardson DR
    J Biol Chem; 2019 Aug; 294(31):11675. PubMed ID: 31375549
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
    Bahar ME; Kim HJ; Kim DR
    Signal Transduct Target Ther; 2023 Dec; 8(1):455. PubMed ID: 38105263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy.
    Trojaniello C; Luke JJ; Ascierto PA
    Front Oncol; 2021; 11():670726. PubMed ID: 34178657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyisoprenylated cysteinyl amide inhibitors induce caspase 3/7- and 8-mediated apoptosis and inhibit migration and invasion of metastatic prostate cancer cells.
    Poku RA; Salako OO; Amissah F; Nkembo AT; Ntantie E; Lamango NS
    Am J Cancer Res; 2017; 7(7):1515-1527. PubMed ID: 28744401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.